New drug shows promise for rare muscle disease in early trial
NCT ID NCT05669014
First seen Nov 03, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This study tested an investigational drug called daxdilimab in 12 adults with dermatomyositis or anti-synthetase myositis that was not well controlled by standard treatments. Participants received either daxdilimab or a placebo to see if the drug could reduce disease activity and skin symptoms over 24 weeks. The goal is to find a safer, more effective option for managing these rare inflammatory muscle diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOSITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accelerium, S. de R.L. de C.V. - PPDS
Monterrey, 64000, Mexico
-
Advanced Research Center, Inc.
Anaheim, California, 92805-5854, United States
-
Aintree University Hospital - NWCRN - PPDS
Liverpool, Merseyside, L9 7AL, United Kingdom
-
Centro Mineiro de Pesquisa - CMiP
Juiz de Fora, Minas Gerais, 36010-570, Brazil
-
Hospital Quironsalud Infanta Luisa
Seville, 41010, Spain
-
LMK Servicos Medicos SS
Porto Alegre, Rio Grande do Sul, 90480-000, Brazil
-
Revmatologicky ustav
Prague, Praha, Hlavní Mesto, 128 00, Czechia
-
Unidad de Investigacion de las Enfermedades Reumaticas S.A. De C.V.
Mexico City, Mexico
-
Western General Hospital Edinburgh - PPDS
Edinburgh, Midlothian, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.